Related Experiment Video
Updated: Aug 25, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells
Yasushi Takenouchi1, Myat Lin Oo, Takeshi Senga
1Division of Cancer Biology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan.
Abstract:
We investigated the tyrosine phosphorylation of NOS3 by active Src. In a cell line derived from human breast cancer, BT474, we found activation of c-Src and tyrosine phosphorylation of NOS3. Phosphorylation of NOS3 was suppressed by treatment of BT474 with PP1, an Src kinase inhibitor, in a dose-dependent manner, suggesting that phosphorylation of NOS3 is catalyzed by active c-Src. Phosphorylation of NOS3 was further examined by a series of Src mutants. In cells expressing v-Src, substantial phosphorylation of NOS3 was observed, whereas NOS3 phosphorylation was not evident in cells expressing c-Src. Similarly, NOS1 was also phosphorylated in cells expressing v-Src. Consistently, in cells expressing a temperature-sensitive mutant of v-Src, NOS3 phosphorylation was temperature-dependent. Moreover, transforming mutant of c-Src, Y527Fc-Src, could activate NOS3 phosphorylation. In contrast, non-myristoylated form of v-Src, G2Av-Src and a kinase-inactive mutant of v-Src, K295Mv-Src, could not activate NOS3 phosphorylation. Taken together, our results suggest that active, membrane-bound form of Src can induce constitutive phosphorylation of NOS3.
Insights
Active Src kinases phosphorylate endothelial nitric oxide synthase (NOS3) in human breast cancer cells. This phosphorylation is dependent on Src activity and its membrane-bound form, suggesting a role in cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Endothelial nitric oxide synthase (NOS3) plays a role in various cellular processes.
- Src kinases are known to regulate cellular signaling pathways, including those implicated in cancer.
Purpose of the Study:
- To investigate the role of active Src in the tyrosine phosphorylation of NOS3.
- To determine the specific forms of Src that mediate NOS3 phosphorylation.
Main Methods:
- Utilized human breast cancer cell line (BT474).
- Employed Src kinase inhibitors (PP1) and various Src mutants (v-Src, c-Src, Y527F, G2A, K295M).
- Analyzed NOS3 phosphorylation levels via Western blotting and kinase activity assays.
Main Results:
- Confirmed activation of c-Src and NOS3 tyrosine phosphorylation in BT474 cells.
- Demonstrated dose-dependent suppression of NOS3 phosphorylation by PP1, indicating Src kinase involvement.
- Observed significant NOS3 phosphorylation with v-Src and Y527Fc-Src, but not with c-Src, G2Av-Src, or K295Mv-Src.
- Showed temperature-dependent NOS3 phosphorylation with a temperature-sensitive v-Src mutant.
Conclusions:
- Active, membrane-bound Src kinases induce constitutive tyrosine phosphorylation of NOS3.
- Specific Src forms and kinase activity are critical for NOS3 phosphorylation.
- Findings suggest a potential mechanism linking Src activity to NOS3 regulation in breast cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

